AKT1 and Esophageal atresia: CAL-101 (50 mg kg−1) induced a significant reduction in basal AKT and S6 phosphorylation (Fig. 5a) and a dose-dependent inhibition of proliferation in both EA cell lines overexpressing the PI3Kδ-L variant (Fig. 5b).